Selected research
Industry Research
Nanotechnology In Medicine and Healthcare Industry Research Report 2026
Market perspective
The global Nanotechnology In Medicine and Healthcare market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Nanotechnology In Medicine and Healthcare market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Nanotechnology In Medicine and Healthcare market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Nanotechnology In Medicine and Healthcare market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Nanotechnology In Medicine and Healthcare include Thermo Fisher Scientific, Nanospectra Biosciences, Nanobiotix, Resonant Nanotechnologies, Abbott Laboratories, Merck and Johnson & Johnson, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Nanotechnology In Medicine and Healthcare market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Nanotechnology In Medicine and Healthcare.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Nanotechnology In Medicine and Healthcare Market by Company
Thermo Fisher Scientific
Nanospectra Biosciences
Nanobiotix
Resonant Nanotechnologies
Abbott Laboratories
Merck
Johnson & Johnson
Nanotechnology In Medicine and Healthcare Segment by Type
Nanoparticles
Nanotubes
Nanowires
Nanorods
Nanostructured Surfaces
Nanotechnology In Medicine and Healthcare Segment by Application
Drug Delivery
Medical Imaging
Disease Diagnosis
Tissue Engineering
Cancer Treatment
Wound Healing
Nanotechnology In Medicine and Healthcare Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nanotechnology In Medicine and Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Nanotechnology In Medicine and Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nanotechnology In Medicine and Healthcare.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Nanotechnology In Medicine and Healthcare companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nanoparticles
- Nanotubes
- Nanowires
- Nanorods
- Nanostructured Surfaces
Applications
- Drug Delivery
- Medical Imaging
- Disease Diagnosis
- Tissue Engineering
- Cancer Treatment
- Wound Healing
Companies covered
- Thermo Fisher Scientific
- Nanospectra Biosciences
- Nanobiotix
- Resonant Nanotechnologies
- Abbott Laboratories
- Merck
- Johnson & Johnson
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Nanotechnology In Medicine and Healthcare by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Nanoparticles
- 2.2.3 Nanotubes
- 2.2.4 Nanowires
- 2.2.5 Nanorods
- 2.2.6 Nanostructured Surfaces
- 2.3 Nanotechnology In Medicine and Healthcare by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Drug Delivery
- 2.3.3 Medical Imaging
- 2.3.4 Disease Diagnosis
- 2.3.5 Tissue Engineering
- 2.3.6 Cancer Treatment
- 2.3.7 Wound Healing
- 2.4 Assumptions and Limitations
3 Nanotechnology In Medicine and Healthcare Breakdown Data by Type
- 3.1 Global Nanotechnology In Medicine and Healthcare Historic Market Size by Type (2021-2026)
- 3.2 Global Nanotechnology In Medicine and Healthcare Forecasted Market Size by Type (2027-2032)
4 Nanotechnology In Medicine and Healthcare Breakdown Data by Application
- 4.1 Global Nanotechnology In Medicine and Healthcare Historic Market Size by Application (2021-2026)
- 4.2 Global Nanotechnology In Medicine and Healthcare Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Nanotechnology In Medicine and Healthcare Market Perspective (2021-2032)
- 5.2 Global Nanotechnology In Medicine and Healthcare Growth Trends by Region
- 5.2.1 Global Nanotechnology In Medicine and Healthcare Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Nanotechnology In Medicine and Healthcare Historic Market Size by Region (2021-2026)
- 5.2.3 Nanotechnology In Medicine and Healthcare Forecasted Market Size by Region (2027-2032)
- 5.3 Nanotechnology In Medicine and Healthcare Market Dynamics
- 5.3.1 Nanotechnology In Medicine and Healthcare Industry Trends
- 5.3.2 Nanotechnology In Medicine and Healthcare Market Drivers
- 5.3.3 Nanotechnology In Medicine and Healthcare Market Challenges
- 5.3.4 Nanotechnology In Medicine and Healthcare Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Nanotechnology In Medicine and Healthcare Players by Revenue
- 6.1.1 Global Top Nanotechnology In Medicine and Healthcare Players by Revenue (2021-2026)
- 6.1.2 Global Nanotechnology In Medicine and Healthcare Revenue Market Share by Players (2021-2026)
- 6.2 Global Nanotechnology In Medicine and Healthcare Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Nanotechnology In Medicine and Healthcare Head Office and Area Served
- 6.4 Global Nanotechnology In Medicine and Healthcare Players, Product Type & Application
- 6.5 Global Nanotechnology In Medicine and Healthcare Manufacturers Established Date
- 6.6 Global Nanotechnology In Medicine and Healthcare Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Nanotechnology In Medicine and Healthcare Market Size (2021-2032)
- 7.2 North America Nanotechnology In Medicine and Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Nanotechnology In Medicine and Healthcare Market Size by Country (2021-2026)
- 7.4 North America Nanotechnology In Medicine and Healthcare Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Nanotechnology In Medicine and Healthcare Market Size (2021-2032)
- 8.2 Europe Nanotechnology In Medicine and Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Nanotechnology In Medicine and Healthcare Market Size by Country (2021-2026)
- 8.4 Europe Nanotechnology In Medicine and Healthcare Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Nanotechnology In Medicine and Healthcare Market Size (2021-2032)
- 9.2 Asia-Pacific Nanotechnology In Medicine and Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Nanotechnology In Medicine and Healthcare Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Nanotechnology In Medicine and Healthcare Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Nanotechnology In Medicine and Healthcare Market Size (2021-2032)
- 10.2 South America Nanotechnology In Medicine and Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Nanotechnology In Medicine and Healthcare Market Size by Country (2021-2026)
- 10.4 South America Nanotechnology In Medicine and Healthcare Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Nanotechnology In Medicine and Healthcare Market Size (2021-2032)
- 11.2 Middle East & Africa Nanotechnology In Medicine and Healthcare Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Nanotechnology In Medicine and Healthcare Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Nanotechnology In Medicine and Healthcare Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in Nanotechnology In Medicine and Healthcare Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific Nanotechnology In Medicine and Healthcare Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Nanospectra Biosciences
- 12.2.1 Nanospectra Biosciences Company Information
- 12.2.2 Nanospectra Biosciences Business Overview
- 12.2.3 Nanospectra Biosciences Revenue in Nanotechnology In Medicine and Healthcare Business (2021-2026)
- 12.2.4 Nanospectra Biosciences Nanotechnology In Medicine and Healthcare Product Portfolio
- 12.2.5 Nanospectra Biosciences Recent Developments
- 12.3 Nanobiotix
- 12.3.1 Nanobiotix Company Information
- 12.3.2 Nanobiotix Business Overview
- 12.3.3 Nanobiotix Revenue in Nanotechnology In Medicine and Healthcare Business (2021-2026)
- 12.3.4 Nanobiotix Nanotechnology In Medicine and Healthcare Product Portfolio
- 12.3.5 Nanobiotix Recent Developments
- 12.4 Resonant Nanotechnologies
- 12.4.1 Resonant Nanotechnologies Company Information
- 12.4.2 Resonant Nanotechnologies Business Overview
- 12.4.3 Resonant Nanotechnologies Revenue in Nanotechnology In Medicine and Healthcare Business (2021-2026)
- 12.4.4 Resonant Nanotechnologies Nanotechnology In Medicine and Healthcare Product Portfolio
- 12.4.5 Resonant Nanotechnologies Recent Developments
- 12.5 Abbott Laboratories
- 12.5.1 Abbott Laboratories Company Information
- 12.5.2 Abbott Laboratories Business Overview
- 12.5.3 Abbott Laboratories Revenue in Nanotechnology In Medicine and Healthcare Business (2021-2026)
- 12.5.4 Abbott Laboratories Nanotechnology In Medicine and Healthcare Product Portfolio
- 12.5.5 Abbott Laboratories Recent Developments
- 12.6 Merck
- 12.6.1 Merck Company Information
- 12.6.2 Merck Business Overview
- 12.6.3 Merck Revenue in Nanotechnology In Medicine and Healthcare Business (2021-2026)
- 12.6.4 Merck Nanotechnology In Medicine and Healthcare Product Portfolio
- 12.6.5 Merck Recent Developments
- 12.7 Johnson & Johnson
- 12.7.1 Johnson & Johnson Company Information
- 12.7.2 Johnson & Johnson Business Overview
- 12.7.3 Johnson & Johnson Revenue in Nanotechnology In Medicine and Healthcare Business (2021-2026)
- 12.7.4 Johnson & Johnson Nanotechnology In Medicine and Healthcare Product Portfolio
- 12.7.5 Johnson & Johnson Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst